Elevated serum and urinary HMGB1 levels have been identified as effective biomarkers for S-AKI, demonstrating high diagnostic accuracy (AUC: 0.891) when combined, outperforming single-sample detection methods (Zang et al., 2022). This evidence concerns the gene HMGB1 and acute kidney injury.